This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

while being able to culture the B-cells with standard procedures. This allows for the isolation of therapeutic antibodies from rare B-cell clones, and accelerated functional screening and ...

BRIUMVI is a novel monoclonal antibody that targets a unique epitope on CD20-expressing B-cells. Targeting CD20 using monoclonal antibodies has proven to be an important therapeutic approach ...

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

Targeting CD20 using monoclonal antibodies has proven to be an important therapeutic approach for the management ... in patients treated with anti-CD20 antibodies. Perform HBV screening in all ...

According to the latest Annual Global Survey by the World Federation of Hemophilia in 2023, there are 809 hemophilia patients ...

The Company has not completed its financial closing procedures for ... expression at desired therapeutic levels. Following treatment with ELEVIDYS, all patients developed anti-AAVrh74 antibodies.

Breast Cancer Diagnostic And Drug Technologies Market Breast cancer is the most common cancer among women worldwide, with an estimated 2.3 ...